| Trial ID: | L5588 |
| Source ID: | NCT01426737
|
| Associated Drug: |
Vildagliptin
|
| Title: |
The Swiss Glucose Variability Study
|
| Acronym: |
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Type 2 Diabetes
|
| Interventions: |
DRUG: Vildagliptin
|
| Outcome Measures: |
Primary: Mean amplitude of glycemic excursion as described by Service et al. (1970) calculated from the glucose excursions of the CGMS profiles using MiniMedSolution Software (MedtronicMiniMed)., 48h |
|
| Sponsor/Collaborators: |
Sponsor: University of Zurich
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
50
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2011-04
|
| Completion Date: |
2013-01
|
| Results First Posted: |
|
| Last Update Posted: |
2011-08-31
|
| Locations: |
Universitiy Hospital, Zurich, Switzerland
|
| URL: |
https://clinicaltrials.gov/show/NCT01426737
|
